Financial statements Pharmaland
Balance sheet data of PHARMALAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 091 743,12 | 2 972 524,43 | 3 350 138,48 | 3 844 393,24 | 3 705 589,32 | 2 294 085,32 |
| A. Fixed assets | 331 218,94 | 202 455,42 | 319 424,20 | 261 334,16 | 173 442,00 | 2 073 416,64 |
| B. Current assets | 2 760 524,18 | 2 770 069,01 | 3 030 714,28 | 3 583 059,08 | 3 532 147,32 | 220 668,68 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 3 091 743,12 | 2 972 524,43 | 3 350 138,48 | 3 844 393,24 | 3 705 589,32 | 2 294 085,32 |
| A. Equity | -2 273 447,78 | -2 704 944,20 | -3 231 429,07 | -2 224 315,80 | -2 199 470,13 | 565 884,09 |
| B. Liabilities and provisions for liabilities | 5 365 190,90 | 5 677 468,63 | 6 581 567,55 | 6 068 709,04 | 5 905 059,45 | 1 728 201,23 |
| I. Long-term liabilities | 0,00 | 0,00 | 732 809,00 | 169 411,51 | 0,00 | 0,00 |
| II. Short-term liabilities | 5 343 588,29 | 5 653 912,08 | 5 826 502,16 | 5 853 076,69 | 5 858 586,73 | 1 728 201,23 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.